InsidersTradesSigma
Discover the full record of transactions filed by Glickman Sarah JS, Chief Financial Officer. Officer active across 3 companies, notably bluebird bio, Inc.. In total, 8 reports have been published. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
8 of 8 declarations
Sarah JS Glickman is a Board Member and Chief Financial Officer at bluebird bio, Inc., 2seventy bio, Inc., and Criteo S.A. She oversees financial operations and is responsible for strategic planning. Her role is crucial in ensuring the financial health of these companies and supporting their growth in the biopharmaceutical sector.